EP Patent

EP3875103B1 — Peptide for promoting mucous membrane permeation and composition containing same

Assigned to Industry Academy Cooperation Foundation of Soonchunhyang University · Expires 2025-06-25 · 1y expired

What this patent protects

Patent listed against difelikefalin-acetate.

Drugs covered by this patent

difelikefalin-acetate (DIFELIKEFALIN ACETATE)

Patent Metadata

Patent number: EP3875103B1
Jurisdiction: EP
Classification: —
Expires: 2025-06-25
Drug substance claim: No
Drug product claim: No
Assignee: Industry Academy Cooperation Foundation of Soonchunhyang University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.